FABTECH147.10

Fabtech Technologies Limited

· Pharma & Health
₹ CrorePeersLAXMIDENTLTARSONSFISCHERGKBMcap ₹654 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
FABTECH
FY26
LAXMIDENTL
FY26
TARSONS
FY26
FISCHER
FY26
Peer
Median
Valuation — at last close
P/E14.71×36.76×118.59×73.33×73.33× -80%
P/B1.56×4.58×2.67×5.99×4.58× -66%
EV/EBITDA17.14×25.26×17.44×54.88×25.26× -32%
Market Cap₹654 Cr₹1,117 Cr₹1,697 Cr₹2,304 Cr₹1,697 Cr -61%
Growth
Revenue YoY (latest Q)10.26%13.87%20.66%249.42%20.66% -50%
Net Income YoY (latest Q)168.73%23.83%-180.99%-24.30%-24.30% +794%
Profitability
EBITDA Margin8.52%15.62%27.91%13.96%15.62% -45%
Net Income Margin9.34%10.41%3.39%10.05%10.05% -7%
Return on Common Equity9.14%11.87%2.26%8.05%8.05% +14%
Return on Capital Employed6.65%10.46%2.32%9.71%9.71% -32%
Return on Assets5.87%9.84%1.21%4.62%4.62% +27%
Credit & Quality
Total Debt/Equity0.10×0.00×0.60×0.19×0.19× -47%
Interest Coverage7.14×20.15×0.95×6.87×6.87× +4%
Scale — latest FY
Revenue / Total Income₹411 Cr₹278 Cr₹423 Cr₹309 Cr₹309 Cr +33%
Net Income₹38.4 Cr₹28.9 Cr₹14.3 Cr₹31 Cr₹28.9 Cr +33%
Total Assets₹654 Cr₹294 Cr₹1,186 Cr₹671 Cr₹671 Cr -3%
EPS₹10₹5.53₹2.69₹0.48₹2.69 +272%
Book Value per Share₹94.43₹44.42₹119.29₹5.88₹44.42 +113%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.